-
If you are a current investor in Arch Chemicals, Inc. (NYSE: ARJ) and purchased your NYSE:ARJ shares prior to the announcement, and/or if you have any information relating the investigation, you have certain options and you should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Investigation Overview
The announcement Arch Chemicals Inc that it agreed to be acquired by Lonza Group Ltd. prompted an investigation on behalf of investors of Arch Chemicals, Inc. (NYSE: ARJ) concerning whether the offer to take over Arch Chemicals and the sale process are unfair to investors of Arch Chemicals (NYSE:ARJ) and whether certain of its officers and directors or others breached their fiduciary duties owed investors in Arch Chemicals (ARJ) shares.
The investigation by a law firm concerns whether the Arch Chemicals, certain of its officers and directors, and/or others breached their fiduciary duties owed to Arch Chemicals, Inc. (NYSE: ARJ) investors in connection with the proposed takeover.
On Monday, July 11, 2011, Arch Chemicals, Inc. (NYSE:ARJ) and Lonza Group Ltd (SIX: LONN) announced that they have signed an agreement pursuant to which Lonza Group Ltd has agreed to commence a tender offer for 100 percent of Arch Chemicals outstanding shares of common stock at a price of USD 47.20 per share in cash.
Arch Chemicals, Inc said that Lonza Group Ltds offer represents a 36.7% premium to Arch Chemicals average closing price over the last 30 trading days.
However, shares of Arch Chemicals, Inc. (NYSE:ARJ) rose from $42.62 on Friday to $46.90 on Monday, leaving stockholders of ARJ shares with only a meager premium.
The investigation concerns whether the Arch Chemicals Board of Directors undertook an adequate and in particular breached their fiduciary duties to the Arch Chemicals, Inc. (NYSE: ARJ) shareholder by failing to adequately shop the Company before entering into the transaction.
The investigation concerns also whether Lonza Group Ltd. would underpay for NYSE: ARJ shares, thus unlawfully harming Arch Chemicals stockholders.
Arch Chemicals annual Revenue rose from $1.3billion in 2007 to $1.37billion in 2010. Its Net Income more than doubled within the same time frame. Its Net Income increased from $35.3million in 07 to $70.70million. For the first quarter in 2011 Arch Chemicals, Inc. reported quarterly Revenue of $325.50million compared to $298.70million one year earlier.
A potential securities class action lawsuit would seek to maximize the amount of money and information NYSE:ARJ shareholders would receive in a buyout, so the law firm.
